Stayble Therapeutics AB
559024-8372ActiveDeveloping an injection treatment for pain caused by disc herniation.
Oversikt
- 5–9
- Ansatte
- 300–399t SEK
- Omsetning
- 2015
- Grunnlagt
Nøkkelbeslutningstakere
Andreas Gerward
CEO
Anders Lehmann
Chief Scientific Officer
Erik Kullgren
Chief Financial Officer
Gunnar Fernström
Board member
+4 flere kontakter i Funnelfeedr
Beskrivelse
Stayble Therapeutics is a clinical pharmaceutical company focused on developing innovative treatments for debilitating leg pain caused by Lumbar Disc Herniation (LDH). Their core product candidate, STA363, is a patented, disease-modifying treatment administered via a single injection. This therapy a...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559024837201
Beslutningstakere
8 kontakter i FunnelfeedrAndreas Gerward
CEO
Anders Lehmann
Chief Scientific Officer
Erik Kullgren
Chief Financial Officer
Gunnar Fernström
Board member
Ulf Björklund
Chairman of the Board
Jane Buus Laursen
Board member
Gudrun Anstrén
Board member
Erik Kinnman
Board member
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrSynartro AB
1–4 ansatteDeveloping sustained local injection treatments for osteoarthritis pain relief.
Paayia Thaimassage
Professional traditional Thai massage services offered in Örebro.
Pharmnovo Aktiebolag
1–4 ansatteDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Intercedo AB
0 ansatteDeveloping medical products focused on improving quality of life.
PILA PHARMA AB
1–4 ansatteClinical stage biotech developing an oral obesity and diabetes treatment.
Utforsk mer
Spørsmål om Stayble Therapeutics AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo